Jazz Pharmaceuticals plcJAZZNASDAQ
LOADING
|||
Switch Symbol:
Revenue Growth Under Pressure
Trending lower, above historical average, strong compound growth.
Left:
||||
Year-over-year revenue growth rate
Latest
7.69%
↑ 128% above average
Average (39q)
3.36%
Historical baseline
Range
High:23.74%
Low:-17.49%
CAGR
+22.7%
Consistent expansion
| Period | Value |
|---|---|
| Q3 2025 | 7.69% |
| Q2 2025 | 16.47% |
| Q1 2025 | -17.49% |
| Q4 2024 | 3.15% |
| Q3 2024 | 3.04% |
| Q2 2024 | 13.51% |
| Q1 2024 | -10.87% |
| Q4 2023 | 4.09% |
| Q3 2023 | 1.55% |
| Q2 2023 | 7.22% |
| Q1 2023 | -8.16% |
| Q4 2022 | 3.35% |
| Q3 2022 | 0.83% |
| Q2 2022 | 14.64% |
| Q1 2022 | -9.26% |
| Q4 2021 | 6.99% |
| Q3 2021 | 11.48% |
| Q2 2021 | 23.74% |
| Q1 2021 | -8.71% |
| Q4 2020 | 10.76% |
| Q3 2020 | 6.84% |
| Q2 2020 | 5.18% |
| Q1 2020 | -8.08% |
| Q4 2019 | 8.19% |
| Q3 2019 | 0.67% |
| Q2 2019 | 5.11% |
| Q1 2019 | 6.66% |
| Q4 2018 | 1.51% |
| Q3 2018 | -6.22% |
| Q2 2018 | 12.57% |
| Q1 2018 | 1.88% |
| Q4 2017 | 5.96% |
| Q3 2017 | 4.43% |
| Q2 2017 | 4.88% |
| Q1 2017 | -5.19% |
| Q4 2016 | 6.00% |
| Q3 2016 | -1.83% |
| Q2 2016 | 13.44% |
| Q1 2016 | -1.43% |
| Q4 2015 | 0.00% |